Prostate Cancer Therapeutics Market By Therapy Type (Hormone Therapy, Biologic Therapy, Chemotherapy, and Targeted Therapy), By Distribution Channel (Retail Pharmacies, Online Pharmacies and Hospitals Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2029

Prostate cancer is a cancer of man’s prostate, a small walnut-sized gland whose function is to produce seminal fluid which nurtures and transports male sperm. Prostate cancer is one of the most common type of cancer in men. Prostate cancer is treatable and can be cured if diagnosed in early stage.

The launches approval of novel drugs indicated for the treatment of prostate cancer is also expected to drastically drive the market growth over forecast period. In May 2018, Sun Pharmaceutical Industries received U.S. Food and Drug Administration approval from for its new drug YONSA, indicated for the treatment of prostate cancer. YONSA (abiraterone acetate) in combination with methylprednisolone is a novel formulation for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC).

Furthermore, high prevalence of prostate cancer is expected to significantly increase demand for prostate cancer therapeutics and drive its market growth over the forecast period. For instance, according to the American Cancer Society in 2018, around 164,690 new cases of prostate cancer is expected to diagnose in U.S. and about 29,430 deaths from prostate cancer is expected to happen due to prostate cancer. Furthermore, 1 man in 9 in U.S. is expected to be diagnosed with prostate cancer during his lifetime.

The  prostate cancer therapeutics market has been segmented on the basis of therapy type, distribution channel, and region.

The therapy type segment includes hormone therapy, biologic therapy, chemotherapy, and targeted therapy.

On the basis of distribution channel, the prostate cancer therapeutics market has been segmented in retail pharmacies, online pharmacies and hospitals pharmacies.

On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account major market share as compared to that of other regions.

Key players operating in the prostate cancer therapeutics market includes,Bayer AG, Johnson & Johnson, AstraZeneca Plc., AstellaInc., Sanofi SA, Pfizer Inc., Dendreon Corporation (Sanpower Group Co. Ltd.), Ipsen Group, TolmarInc, Endo Pharmaceuticals, AbbVie, Inc.

Table of Contents

1. Research Objective and Assumption
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Preview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Therapy Type
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Opportunity Map Analysis
3. Market Dynamics Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
     • Drivers- Restraints Impact Analysis
     • PEST Analysis
     • Porter’s Five Forces Analysis
4. Market Segmentation, By Therapy Type , 2018 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2018 and 2028 (%)
     • Y-o-Y Growth Analysis (%), 2019 – 2028
     • Segment Trends

o    Hormone Therapy

• Introduction
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
• Biologic Therapy
  • Introduction
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028

o    Chemotherapy

• Introduction
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028

o    Targeted Therapy

• Introduction
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028

1. Market Segmentation, Distribution Channel, 2018 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2018 and 2028 (%)
     • Y-o-Y Growth Analysis (%), 2019 – 2028
     • Segment Trends
   • Retail Pharmacy
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
   • Online Pharmacy
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
   • Hospitals
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
2. Global Market, By Region, 2018 – 2028, (US$ Mn)
   • Introduction
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
     • Y-o-Y Growth Analysis (%), 2019 – 2028
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Mn), By Therapy Type, 2018 – 2028
     • Market Size and Forecast (US$ Mn), By Distribution Channel, 2018 – 2028
     • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  U.S.

Ø  Canada

• Latin America
  • Market Size and Forecast (US$ Mn), By Therapy Type, 2018 – 2028
  • Market Size and Forecast (US$ Mn), By Distribution Channel, 2018 – 2028
  • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  Brazil

Ø  Mexico

Ø  Argentina and Chile   

Ø  Rest of Latin America

• Europe
  • Market Size and Forecast (US$ Mn), By Therapy Type, 2018 – 2028
  • Market Size and Forecast (US$ Mn), By Distribution Channel, 2018 – 2028
  • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  Germany

Ø  UK

Ø  France

Ø  Russia

Ø  Italy

Ø  Switzerland

Ø  Sweden

Ø  Rest of Europe           

• Asia Pacific
  • Market Size and Forecast (US$ Mn), By Therapy Type, 2018 – 2028
  • Market Size and Forecast (US$ Mn), By Distribution Channel, 2018 – 2028
  • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  China

Ø  India

Ø  Australia & New Zealand

Ø  Japan

Ø  South Korea

Ø  Rest of Asia Pacific

• Middle East
  • Market Size and Forecast (US$ Mn), By Therapy Type, 2018 – 2028
  • Market Size and Forecast (US$ Mn), By Distribution Channel, 2018 – 2028
  • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  GCC

Ø  Israel

Ø  Saudi Arabia

Ø  UAE

Ø  Rest of Middle East

• Africa
  • Market Size and Forecast (US$ Mn), By Therapy Type, 2018 – 2028
  • Market Size and Forecast (US$ Mn), By Distribution Channel, 2018 – 2028
  • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  North Africa

Ø  Central Africa

Ø  South Africa

1. Competitive Landscape
   • Heat Map Analysis
   • Company Profiles
     • AstraZenca Plc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

§  Bayer AG

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

• Johnson & Johnson

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

• Astella Inc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

• Sanofi SA

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

• Pfizer Inc

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

• Dendreon Corporation (Sanpower Group Co. Ltd.)

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

• Ipsen Group. 

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

• Tolmar Inc. 

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

§  Endo Pharmaceuticals

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

• AbbVie, Inc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

• Analyst Views

1. Section
   • Research Methodology
   • About Us
   • Contact